Tata Chemicals Europe announced the closure of its Lostock Gralam soda ash plant, bringing 150 years of manufacturing history ...

Bernstein analysts maintained their positive stance on Eli Lilly (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $1,100.00. The endorsement comes amidst a competitive ...

The concerns over U.S. tech stocks come during a week when many of the sector's key companies will report earnings. Meta, ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Pharma stocks have underperformed the market in the fourth quarter with the Stoxx Europe 600 Health Care index--which is heavily dominated by Europe's six largest pharma companies--down 9.4% against a ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

It was an everyday situation that became a nightmare no parent should have to face. Two-year-old Ava Hodgkinson was under the ...

The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...

The Ibn Sina Pharmaceutical Industry's profit grew marginally in the second quarter of fiscal year 2024-25. The company's ...

It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...

The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.